Research results from study with Multi Frequency Vibrometry on children and adolescents will be presented as a poster presentation

Research results from study with Multi Frequency Vibrometry on children and adolescents will be presented as a poster presentation at the American Diabetes Association’s Scientific Sessions

Physician and PhD student Erik Ising at Skåne University Hospital and Lund University, Sweden, will present research findings at the American Diabetes Association’s Scientific Sessions in San Diego, USA, in June 2017. Erik Ising conducted a study on children and adolescents with type 1 diabetes mellitus using Multi Frequency Vibrometry to investigate whether occurrence of nerve damage in hands and feet caused by diabetes could be detected

Erik Ising have conducted a study using Multi Frequency Vibrometry to investigate vibrotactile sense in order to see whether it is possible to identify individuals with early sensory impairment, in hands and feet, among children and adolescents with type 1 diabetes mellitus.

- The results of this study are interesting. We are pleased to have the opportunity to present it at the American Diabetes Association’s Scientific Sessions, says Erik Ising, physician and PhD student at Skåne University Hospital and Lund University, Sweden.

As a reminder, all information contained in the submitted abstract should be considered preliminary and subject to change until presented at the 77th Scientific Sessions.

Information subject to embargo until 10:00 pm, Pacific Time, Saturday June 10, 2017.

Contact information
Toni Speidel, CEO, VibroSense Dynamics AB, +46 40 650 14 12, info@vibrosense.com, www.vibrosense.com

About VibroSense Dynamics AB (public)
VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms.

About Us

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms. The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands. www.vibrosense.com

Subscribe

Documents & Links